08.14.2018 Issue 414

Visit HealthEconomics.Com Subscribe to Newsletters  |  Contact Us  |  Forward to a Friend
Sponsored by:

This Week's HEOR Round-up
The Top Story in HEOR: Latest Headlines in HEOR:

Benchmarking Market Access Strategies
for High-Cost Drugs and Biologics

Saturday, August 11

What is the secret of commercial success for high cost specialty drugs? More specifically, what do the companies that overcome affordability and value demonstration issues do differently?

U.K. Wants Price Controls Applied to Biosimilars

Improving MACRA’s Quality Payment Program, MIPS

Report: Eli Lilly Ignoring California’s Price Hike Notice Law

Article: AI at ‘Forefront of Healthcare Revolution’

Trump Administration Closes Medicaid Loophole on Drug Rebates

Vertex Pharmaceuticals Continues to Spar with U.K. Government

Express Scripts Blocks 48 Drugs

AMCP Amazon Web Services White Paper Spotlights Cloud, RWE

Adjunct Faculty, Economics of Health Care, on-line

Watson Health - Lead Research Analyst (Outcomes Research)

Watson Health - Senior SAS Programmer Analyst

Watson Health - Statistician/ Sr Statistician (HEOR/medical claims data)

Watson Health - Outcomes Researcher

Senior Principal - Health Economics

Principal - HTA

Principal, Health Economics

Industry Spotlight

Conferences Webinars
6th Annual Reimbursement and Access
    August 15-16, Philadelphia, Pennsylvania

Partnering with IDNs BioPharma Strategy Summit
    August 15-16, Philadelphia, Pennsylvania

World Congress on Biosensors and Bioelectronics
    August 20-21, Chicago, Illinois

340B Manufacturer Summit
    August 21-22, Washington, D.C.

Bio/Pharma Forum on the State of Medicare Reform
    August 21, Arlington, Virginia

The Building Blocks of Successful Outcomes in Data-Driven Clinical Trials
    August 14

Tackling the Top 5 Barriers for Medication Adherence
    August 15

The Next Generation PSP: How to Maximize Patient Outcomes and Boost Patient Experience Through More Advance PSP Design
    August 30

PROving Its Worth: How to Develop a PRO Strategy to Distinguish Your Product with Regulators and Payers
    September 12

Conference of the Week Webinar of the Week Job of the Week Link of the Week

Syndicated Reports White Papers
Benchmarking Market Access Strategies for High-Cost Drugs and Biologics

HTA in Europe: Key Success Factors for Positive HTA Recommendations

Paying for Digital Health: Payer Insights

Benchmarking Pharma’s MSL Capabilities

Biosimilars: U.S. Payer Perspectives

KAM Metrics: Driving Efficiency, Measuring Success

A Holistic Approach to Payment Accuracy Helps Drive Cost Savings

Improving Patient Matching with a Simple Plug-In

Real-World Evidence in the Cloud: How Technology is Revealing the Big Picture in Pharma

How Payers Can Save an Average of $25,579 Per Patient by Eliminating Unwarranted, Non-Evidence-Based Cancer Treatment

ICER’s Reference Case for Economic Evaluations: Principles and Rationale

Special Thanks to Our Partners:
         Evidera   HealthCore     University of FL   Truven
      Xcenda  OM1    Parexel   Jefferson   Dymaxium
      Precision Xtract    Pharmerit    eMax Health   Sciformix
      Evidence Partners    ICON